e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Involvement of the CD40-CD154 interaction in the regulation of surfactant production and development of secondary pulmonary alveolar proteinosis
M. Shibasaki, T. Kawabe, K. Hashimoto, K. Imaizumi, N. Hashimoto, K. Shimokata, Y. Hasegawa (Oobu, Nagoya, Japan)
Source:
Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Session:
What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Session type:
E-Communication Session
Number:
4762
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Shibasaki, T. Kawabe, K. Hashimoto, K. Imaizumi, N. Hashimoto, K. Shimokata, Y. Hasegawa (Oobu, Nagoya, Japan). Involvement of the CD40-CD154 interaction in the regulation of surfactant production and development of secondary pulmonary alveolar proteinosis. Eur Respir J 2009; 34: Suppl. 53, 4762
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Pathology of ILDs
Related content which might interest you:
The role of apoptosis in idiopathic pulmonary alveolar proteinosis
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002
Possible ocular involvement in pulmonary alveolar proteinosis
Source: Eur Respir J 2006; 28: 456
Year: 2006
Low telomerase expression in alveolar epithelial plays a role in the pathogenesis of idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Surfactant proteins in pulmonary alveolar proteinosis in adults
Source: Eur Respir J 2004; 24: 426-435
Year: 2004
Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis
Source: ERJ Open Res, 4 (1) 00071-2017; 10.1183/23120541.00071-2017
Year: 2018
Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis
Source: Eur Respir J 2012; 39: 777-780
Year: 2012
Peculiarities of pulmonary alveolar proteinosis (PAP) due to exogenous factors
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020
Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017
Defective surfactant biosynthesis and ultrastructural abnormalities of alveolar type 2 cells in pulmonary fibrosis of conditional Nedd4-2mice
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
The analysis of alveolar macrophage form in secondary pulmonary alveolar proteinosis complicated with myelodysplastic syndrome.
Source: International Congress 2017 – Rare diseases
Year: 2017
Alveolar macrophage proteinase/antiproteinase expression in lung function and emphysema
Source: Eur Respir J 2014; 43: 82-91
Year: 2004
Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002
Regulation of pulmonary inflammation and its consequences by collectins and apoptotic cells
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004
Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
M2 polarized alveolar macrophages in pulmonary fibrosis
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages
Source: Eur Respir J, 55 (1) 1900646; 10.1183/13993003.00646-2019
Year: 2020
A crucial role for lung interstitial macrophages in preventing airway allergy
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009
Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept